ABP 株価分析 — Abpro Holdings, Inc. (Healthcare >> Biotechnology)
ABP に関するよくある質問
ABPのPER(株価収益率)は?
Abpro Holdings, Inc.(ABP)は現在PER 2.76倍で取引されています。
ABPのROE(自己資本利益率)は?
Abpro Holdings, Inc.のROEは32.75%です。
ABPの配当利回りは?
Abpro Holdings, Inc.の配当利回りは0.00%です。
ABPの品質スコア(Quality Score)は?
当社のAIはABPの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ABPは今が買い時ですか?
当社AIのタイミングスコアは100点中3点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ABPはどのセクターに属しますか?
Abpro Holdings, Inc.はHealthcare >> Biotechnologyセクターに分類されます(NYSE市場)
ABP AI Analysis Summary
Our AI summary for ABP: Abpro Holdings, Inc. (NYSE), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 2.76, ROE of 32.75%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 3/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 5.70
Price
0.10
(1.75%)
Day Change
|
|
|---|
ABP, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROAが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.70 |
| PBV / Sector |
-1.88 / 44,022.72
|
| Earning Per Share | -1.06 |
| PE / Sector |
2.76 / 19.17
GREAT
|
| PEG or PE/Growth / Sector |
-0.08 / 1.24
|
| Average 1M Daily Value |
0.02 M
GREAT
|
| Average 1W Daily Value |
0.02 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
52% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-05 07:59:46 |
| Symbol | ABP |
| Name | ABPRO HOLDINGS, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE |
| Listed Shares | 2.72 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 15.58 / 9,586.08 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 68 Cummings Park Drive, Woburn, MA, United States, 01801
Phone: 800 396 5890
Website: https://abpro.co
Sector: Healthcare >> Biotechnology
Description: Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google